Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Essential role of sphingosine 1–phosphate receptor 2 in pathological angiogenesis of the mouse retina
Athanasia Skoura, … , Richard L. Proia, Timothy Hla
Athanasia Skoura, … , Richard L. Proia, Timothy Hla
Published September 4, 2007
Citation Information: J Clin Invest. 2007;117(9):2506-2516. https://doi.org/10.1172/JCI31123.
View: Text | PDF
Research Article Ophthalmology

Essential role of sphingosine 1–phosphate receptor 2 in pathological angiogenesis of the mouse retina

  • Text
  • PDF
Abstract

Sphingosine 1–phosphate (S1P), a multifunctional lipid mediator that signals via the S1P family of G protein–coupled receptors (S1PR), regulates vascular maturation, permeability, and angiogenesis. In this study, we explored the role of S1P 2 receptor (S1P2R) in normal vascularization and hypoxia-triggered pathological angiogenesis of the mouse retina. S1P2R is strongly induced in ECs during hypoxic stress. When neonatal mice were subjected to ischemia-driven retinopathy, pathologic neovascularization in the vitreous chamber was suppressed in S1p2–/– mice concomitant with reduction in endothelial gaps and inflammatory cell infiltration. In addition, EC patterning and normal revascularization into the avascular zones of the retina were augmented. Reduced expression of the proinflammatory enzyme cyclooxygenase-2 (COX-2) and increased expression of eNOS were observed in the S1p2–/– mouse retina. S1P2R activation in ECs induced COX-2 expression and suppressed the expression of eNOS. These data identify the S1P2R-driven inflammatory process as an important molecular event in pathological retinal angiogenesis. We propose that antagonism of the S1P2R may be a novel therapeutic approach for the prevention and/or treatment of pathologic ocular neovascularization.

Authors

Athanasia Skoura, Teresa Sanchez, Kevin Claffey, Suzanne M. Mandala, Richard L. Proia, Timothy Hla

×

Figure 7

S1P2R negatively regulates eNOS expression during hypoxia.

Options: View larger image (or click on image) Download as PowerPoint
S1P2R negatively regulates eNOS expression during hypoxia.
             ...
(A) eNOS and actin protein expression in HT and KO retinas at P14 (2 days of hypoxia); HUVEC extract was used as positive control. eNOS expression was increased by 1.6-fold in KO retinas (*P ≤ 0.05) (B) Western blot analysis of extracts from HUVECs transduced with AdGFP or AdS1P2-V5 (20 MOI). Immunoblotting for eNOS, S1P2-V5, and actin expression. Levels of eNOS in HUVECs transduced with AdS1P2-V5 were decreased by 2.3-fold (**P < 0.02; results from 1 representative experiment, n = 5).

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts